OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential therapeutic targets for sarcopenia identified by Mendelian randomisation
Wei Jiang, Wenli Zhan, Luo‐Qi Zhou, et al.
Age and Ageing (2023) Vol. 52, Iss. 2
Open Access | Times Cited: 19

Showing 19 citing articles:

Systematic druggable genome‐wide Mendelian randomization identifies therapeutic targets for sarcopenia
Kang‐Fu Yin, Ting Chen, Xiaojing Gu, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 4, pp. 1324-1334
Open Access | Times Cited: 10

Association Analysis of the Circulating Proteome With Sarcopenia‐Related Traits Reveals Potential Drug Targets for Sarcopenia
Simin Wen, Siqi Xu, Xizeng Zong, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 1
Open Access

An Attention‐Aware Multi‐Task Learning Framework Identifies Candidate Targets for Drug Repurposing in Sarcopenia
Md. Selim Reza, Chuan Qiu, Lin Xu, et al.
Journal of Cachexia Sarcopenia and Muscle (2025) Vol. 16, Iss. 2
Open Access

New research progress of sarcopenia in surgically resectable malignant tumor diseases
Bing Fu, Lei Hu, Ji Hui, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access

Identifying genetic determinants of sarcopenia-related traits: a Mendelian randomization study of druggable genes
Jihao Wu, Xiong Chen, Ruijun Li, et al.
Metabolism (2024) Vol. 160, pp. 155994-155994
Closed Access | Times Cited: 3

Advancements in Drug Delivery Systems for the Treatment of Sarcopenia: An Updated Overview
Alfred Najm, Elena-Theodora Moldoveanu, Adelina-Gabriela Niculescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10766-10766
Open Access | Times Cited: 1

HMGCR as a promising molecular target for therapeutic intervention in aortic aneurisms: a mendelian randomization study
Peng‐Fei Zheng, Zhaofen Zheng, Peng Liu, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization
Qijun Wang, Xuan Zhao, Shuai-Kang Wang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113687-113687
Open Access | Times Cited: 1

Age Is Just a Number: Progress and Obstacles in the Discovery of New Candidate Drugs for Sarcopenia
Hyun-Jun Kim, Da‐Woon Jung, Darren R. Williams
Cells (2023) Vol. 12, Iss. 22, pp. 2608-2608
Open Access | Times Cited: 3

Investigating the Causal Effects of Exercise-Induced Genes on Sarcopenia
Li Wang, Song Zhang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10773-10773
Open Access

Exploring the Relationship Between Gut Microbiota and Sarcopenia Based on Gut–Muscle Axis
Wei Li, Renwang Sheng, Mu‐Min Cao, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 11, pp. 8779-8792
Open Access

Precision mitochondrial medicine: Uncovering pathways across diverse diseases
Lourdes Sainero‐Alcolado, Elisa Garde-Lapido, Judit Liaño-Pons, et al.
Elsevier eBooks (2024), pp. 115-169
Closed Access

Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation
Qinqing Lin, Kangyong Li, Liwei Li, et al.
Aging Clinical and Experimental Research (2024) Vol. 37, Iss. 1
Open Access

Page 1

Scroll to top